Back to Search
Start Over
The First Case of TEMPI Syndrome in Japan.
- Source :
-
Internal medicine (Tokyo, Japan) [Intern Med] 2020 Jul 15; Vol. 59 (14), pp. 1741-1744. Date of Electronic Publication: 2020 Apr 16. - Publication Year :
- 2020
-
Abstract
- TEMPI syndrome, a disease entity comprising telangiectasia, erythrocytosis with high erythropoietin, monoclonal gammopathy, perinephric fluid collection, and intrapulmonary shunting, was first described by Sykes et al. in 2011. To our knowledge, only 15 cases have been reported worldwide, none of which were in Japan. We herein report a 47-year-old man who had intractable ascites for 2 and a half years and was referred to our department for a peritoneovenous shunt. In addition to ascites, he had telangiectasia, high erythropoietin, monoclonal gammopathy, and perinephric fluid collection. Thus, this is the first case of TEMPI syndrome in Japan.
- Subjects :
- Humans
Japan epidemiology
Male
Middle Aged
Monoclonal Gammopathy of Undetermined Significance diagnosis
Monoclonal Gammopathy of Undetermined Significance epidemiology
Polycythemia diagnosis
Polycythemia epidemiology
Telangiectasis diagnosis
Telangiectasis epidemiology
Treatment Outcome
Antibodies, Monoclonal therapeutic use
Antineoplastic Agents therapeutic use
Bortezomib therapeutic use
Monoclonal Gammopathy of Undetermined Significance drug therapy
Polycythemia drug therapy
Telangiectasis drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1349-7235
- Volume :
- 59
- Issue :
- 14
- Database :
- MEDLINE
- Journal :
- Internal medicine (Tokyo, Japan)
- Publication Type :
- Academic Journal
- Accession number :
- 32295999
- Full Text :
- https://doi.org/10.2169/internalmedicine.3547-19